Join Veristat and hundreds of Clinical Operations/Development/Research and Medical Affairs pharma and biotech representatives in the northeast region for the Clinical Operations in Oncology Trials East 2017 Conference.
Join Veristat and hundreds of Clinical Operations/Development/Research and Medical Affairs pharma and biotech representatives in the northeast region for the Clinical Operations in Oncology Trials East 2017 Conference.
SOUTHBOROUGH, MA – June 19, 2017 – Veristat, a full service Clinical Research Organization (CRO), announced today that Veristat and AOBiome, a clinical-stage life sciences company advancing patented microbiome-targeted therapies for systemic and local inflammatory conditions, have entered into a Preferred Provider Agreement (PPA).
The DIA 2017 Annual Meeting’s theme this year is “driving insights to action” and Veristat is ready to take that challenge!
Employees at Veristat handle complex work that is both rewarding and meaningful. Our team members are dedicated partners to internal colleagues and external clients alike.
Our values include:
If this sounds like an environment you would thrive in, then click below to learn more about us.
Since the day Veristat was formed, our approach has focused on partnership. We aren’t here to complicate your studies, we are here to be a true extension of your team, to build enduring partnerships, to be a trust-worthy teacher and respected team member.
We are here to be TRUE Partners to You.
Our teams support amazing, cutting-edge, life-enhancing and life-saving therapies that range from novel vaccines for global pandemics to new approaches for treating fungal infections to the latest immunotherapies to eradicate cancer. We have the right expertise and therapeutic understanding and creative know-how to help you design, build, and run your clinical development program in any therapeutic area.
Our current ongoing projects focus for therapies to treat Cancers, Rare Diseases, Neurological Disorders, Cardiovascular Disease, Infectious Diseases and more.
